ASPAVIM 167mg / 175mg capsules medication leaflet

A12BA30 monopotassium aspartate + magnesium aspartate • Alimentary tract and metabolism | Potassium

Magnesium aspartate and potassium aspartate are mineral salts used in the treatment and prevention of magnesium and potassium deficiencies. These minerals are essential for normal cellular function, including muscle activity, nerve conduction, and electrolyte balance.

This combination is administered orally, usually in the form of tablets or solutions, and is indicated for patients with low magnesium and potassium levels caused by conditions such as chronic diarrhea, prolonged vomiting, or diuretic use. It is also used to prevent cardiac arrhythmias associated with electrolyte imbalances.

Common side effects include abdominal discomfort, diarrhea, and nausea. In rare cases, severe adverse reactions such as hypermagnesemia or hyperkalemia may occur, especially in patients with renal impairment. Regular monitoring of serum magnesium and potassium levels is essential during treatment.

Magnesium aspartate and potassium aspartate are effective and well-tolerated options for correcting electrolyte imbalances, contributing to cardiovascular and neuromuscular health maintenance.

General data about ASPAVIM 167mg / 175mg

Substance: monopotassium aspartate + magnesium aspartate

Date of last drug list: 01-07-2013

Commercial code: W13237001

Concentration: 167mg / 175mg

Pharmaceutical form: capsules

Quantity: 50

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Pharmaceutical forms available for monopotassium aspartate + magnesium aspartate

Concentrations available for monopotassium aspartate + magnesium aspartate

167mg/175mg, 180mg/180mg, 39mg/12mg